Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults.
Díez-Domingo J, Tinoco JC, Poder A, Dinleyici EC, Nell H, Salamanca de la Cueva I, Ince T, Moreira ED Jr, Ahmed K, Luz K, Kovshirina Y, Medina Pech CE, Akhund T, Romolini V, Costantini M, Mzolo T, Kunnel B, Lechevin I, Aggravi M, Tiberi P, Narendran K, García-Martínez JA, Basile V, Fragapane E, Lattanzi M, Pellegrini M. Díez-Domingo J, et al. Among authors: fragapane e. Hum Vaccin Immunother. 2022 Dec 31;18(1):1981085. doi: 10.1080/21645515.2021.1981085. Epub 2021 Oct 6. Hum Vaccin Immunother. 2022. PMID: 34614379 Free PMC article. Clinical Trial.
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
Vandermeulen C, Leroux-Roels I, Vandeleur J, Staniscia T, Girard G, Ferguson M, Icardi G, Schwarz TF, Neville AM, Nolan T, Cinquetti S, Akhund T, Van Huyneghem S, Aggravi M, Kunnel B, de Wergifosse B, Domenico GFD, Costantini M, Vir Singh P, Fragapane E, Lattanzi M, Pellegrini M. Vandermeulen C, et al. Among authors: fragapane e. Vaccine. 2021 Oct 29;39(45):6628-6636. doi: 10.1016/j.vaccine.2021.09.068. Epub 2021 Oct 9. Vaccine. 2021. PMID: 34635373 Free article. Clinical Trial.
One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.
Cramer JP, Jelinek T, Paulke-Korinek M, Reisinger EC, Dieckmann S, Alberer M, Bühler S, Bosse D, Meyer S, Fragapane E, Costantini M, Pellegrini M, Lattanzi M, Dovali C. Cramer JP, et al. Among authors: fragapane e. J Travel Med. 2016 Mar 19;23(3):taw011. doi: 10.1093/jtm/taw011. Print 2016 Mar. J Travel Med. 2016. PMID: 26994987 Clinical Trial.
A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults.
Herbinger KH, von Sonnenburg F, Nothdurft HD, Perona P, Borkowski A, Fragapane E, Nicolay U, Clemens R. Herbinger KH, et al. Among authors: fragapane e. Hum Vaccin Immunother. 2014;10(1):92-9. doi: 10.4161/hv.26495. Epub 2013 Sep 20. Hum Vaccin Immunother. 2014. PMID: 24047817 Free PMC article. Clinical Trial.
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.
Banzhoff A, Pellegrini M, Del Giudice G, Fragapane E, Groth N, Podda A. Banzhoff A, et al. Among authors: fragapane e. Influenza Other Respir Viruses. 2008 Nov;2(6):243-9. doi: 10.1111/j.1750-2659.2008.00059.x. Influenza Other Respir Viruses. 2008. PMID: 19453401 Free PMC article. Review.
Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the Italian population.
Bergamini M, Comodo N, Gasparini R, Gabutti G, Fabrizi P, Severini R, Ajello F, Bonanni P, Castagnari L, Cocchioni M, Della Pietra P, Fragapane E, Grilli A, Liberatore S, Lo Nostro A, Moiraghi-Ruggenini A, Pellegrini MG, Pozzi T, Tarsitani G, Zotti C, Crovari P. Bergamini M, et al. Among authors: fragapane e. Vaccine. 1999 Jan 21;17(3):286-90. doi: 10.1016/s0264-410x(98)00053-x. Vaccine. 1999. PMID: 9987165 Clinical Trial.
24 results